Rama Phosphates Limited (RAMAPHO) fair value: what the stock is really worth
As of Oct 1, 2026: fair value of Rama Phosphates Limited ₹120, price ₹120, upside +0.3%, quality 57 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Rama Phosphates Limited for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 27, 2026.
How to read this chart
50‑month range ₹74.64 – ₹210.57 · fair‑value band ₹105.97 – ₹168.47 · the ₹120.05 price screens below the ₹120.41 fair value. Dashed = 300-day average. As of Sep 27, 2026.
Follow Rama Phosphates in your weekly email
Every Wednesday you see whether Rama Phosphates is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Rama Phosphates Limited manufactures and sales phosphatic fertilizers, chemicals, soya, and micronutrients in India. It operates through Fertilizers and Micronutrients; Chemicals; and Oil segments.
Show more
Rama Phosphates Limited manufactures and sales phosphatic fertilizers, chemicals, soya, and micronutrients in India. It operates through Fertilizers and Micronutrients; Chemicals; and Oil segments. The company offers powder and granular single super phosphate fertilizers; various grades of nitrogen phosphorus potash mixed fertilizers; fortified fertilizers, such as boronated and zincated single super phosphate fertilizers, and zincated boronated GSSP; potash derived from molasses and boron; water soluble fertilizers, calcium nitrate, and sulphur DP; micronutrients; and water-soluble complex fertilizers. It also provides chemicals comprising sulphuric acid, oleum, sodium silico fluoride, Labsa, and chlorosulphonic acid; and edible soya, lecithin, and soya de oiled cakes. It offers its products under the Girnar, Suryaphool, and Sampurn brand names. Rama Phosphates Limited was incorporated in 1984 and is headquartered in Mumbai, India. Rama Phosphates Limited is a subsidiary of Silver Eagle Inc.
Stock analysis
Rama Phosphates Limited (RAMAPHO) currently trades at ₹120.05, while our model-based Fair Value estimate is ₹120.41, so the stock looks roughly fairly valued today (gap 0.3%).
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of ₹274.85 per share, and 14 of the 17 models we run sit above the ₹120.05 price.
Bear case: the Asset-Based group reads lowest at ₹79.99, and 3 of the 17 models stay below the price. Evidence for this calculation is high.
Scenario range: ₹105.97 (bear) to ₹168.47 (bull), the price of ₹120.05 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 57/100 (solid quality), in the Basic Materials sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Rama Phosphates Limited reported revenue of ₹8.9B in FY2026 versus ₹4.9B in FY2022, a compound +16.2%/yr. Reported net income was ₹527M in FY2026, compounding −6.9%/yr from FY2022.
Key figures
Market cap ₹4.2B (≈ $44.1M) · P/E ratio 8.1 · P/S ratio 0.48 · EPS (TTM) ₹14.89 · Dividend yield 0.6% · Net margin 5.9% · Return on equity 13.3% · Return on assets (EBIT) 2.7%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (low confidence).
What moves the price
The share trades about 43% below its 52-week high and 15% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at 17% fair-value upside, at 0%, RAMAPHO screens richer than that median.
Fair Value models
Bear ₹105.97Fair Value ₹120.41Bull ₹168.47
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2026 figures (about 6 months old). Earnings retained since then (₹7.17 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.55/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+73.5%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+16.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+14.0%
Start year 2021 (pandemic). Over 10 years: +8.7% a year
Revenue growth 19 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.7%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
’26
What shareholders gained per year (last 5 years), in INR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: EBIT basis. Measured in INR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
≈ +7.8%
Earnings growth per share plus dividend.
Earnings per share, growth per year+7.2%
Dividend (yield on the price)0.6%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.4.6% vs 20.3%, slowing
Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.12% → 9%
Start year 2021 (pandemic)
⚠ Rate on operating basis: 2026 sits 93% above its own trend.
Compare Rama Phosphates Limited with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Agricultural Inputs · 170 stocks
Beats the industry median on 11/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score57 · Above median
Fair Value upside+0.3% · Above median
Profitability
Return on equity (TTM)13.3% · Above median
Return on assets7.4% · Top 25%
Net margin (TTM)5.9% · Above median
Operating margin (TTM)3.7% · Below median
Growth and dividend
Revenue growth9.0% · Above median
Dividend yield (TTM)0.6% · Bottom 25%
Balance sheet
Debt / equity0.01× · Below median
Valuation Multiplesvs Agricultural Inputs median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Rama Phosphates Limited (RAMAPHO) overvalued or undervalued?
As of Sep 27, 2026, our model estimates a fair value of ₹120.41 versus a price of ₹120.05, about +0% upside (fairly valued).
What is the fair value of RAMAPHO?
Our model-based fair value for Rama Phosphates Limited is ₹120.41 (as of Sep 27, 2026), built from audited fundamentals. The current price: ₹120.05.
What is the quality score of RAMAPHO?
Rama Phosphates Limited has a Quality Score of 57/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Rama Phosphates Limited (RAMAPHO)?
Our model-based price target is the fair value of ₹120.41 (as of Sep 27, 2026) from 17 valuation models. Cautious scenario ₹105.97, optimistic scenario ₹168.47. It is a calculation from audited fundamentals, not an analyst target.
What is the Rama Phosphates Limited stock forecast for 2026?
Our models put fair value at ₹120.41, about +0% upside versus a price of ₹120.05 (fairly valued). Cautious scenario ₹105.97, optimistic scenario ₹168.47. The calculation is refreshed regularly with new filings.
What is the revenue of Rama Phosphates Limited (RAMAPHO)?
Rama Phosphates Limited reported trailing-twelve-month revenue of about ₹8.9B (latest available figure, as of Sep 27, 2026).
Does Rama Phosphates Limited pay a dividend?
Rama Phosphates Limited currently shows a dividend yield of about 0.62% relative to its recent price (as of Sep 27, 2026).
What is the intrinsic value of Rama Phosphates Limited (RAMAPHO)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Rama Phosphates Limited it is ₹120.41 per share (as of Sep 27, 2026), against a price of ₹120.05. It is the blended result of 17 valuation models (cash flow, earnings, asset, dividend).
Is Rama Phosphates Limited stock overvalued or undervalued in 2026?
As of Sep 27, 2026, RAMAPHO trades below its calculated fair value: price ₹120.05, fair value ₹120.41, a gap of about +0% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of RAMAPHO?
No. The price is what the market pays today (₹120.05); the fair value is what the company's own numbers justify (₹120.41). For Rama Phosphates Limited the two are ₹0.3600 per share apart. That gap is exactly why we show both numbers side by side.
How much is Rama Phosphates Limited worth?
The market values Rama Phosphates Limited at about ₹4.2B (market capitalisation, as of Sep 27, 2026). Per share that is ₹120.05; our models calculate a fair value of ₹120.41 per share.
What do the bullish and bearish scenarios say about RAMAPHO?
Our models span a range for Rama Phosphates Limited: cautious scenario ₹105.97, base ₹120.41, optimistic ₹168.47 per share (as of Sep 27, 2026, price ₹120.05). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of RAMAPHO?
Rama Phosphates Limited trades at a price-to-earnings ratio of 8.1 (as of Sep 27, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹120.41 is built from several models across several years. Other multiples: P/B 1.0, P/S 0.5, EV/EBITDA 4.8.
How solid is the balance sheet of Rama Phosphates Limited (RAMAPHO)?
Balance-sheet figures for Rama Phosphates Limited (as of Sep 27, 2026): return on equity 13.3%, debt of 0.01 per unit of equity. They feed the Quality Score of 57/100, which measures business quality independently of the share price.
How far is RAMAPHO from its 52-week high?
Rama Phosphates Limited trades at ₹120.05, about 43% below its 52-week high of ₹210.57 and 15% above the low of ₹104.03 (as of Oct 1, 2026). Distance from the high says nothing about value: that is what the fair value of ₹120.41 is for.
Which stocks are comparable to Rama Phosphates Limited?
From the same area (Basic Materials) we also value Corteva, Inc, Nutrien Ltd, Qinghai Salt Lake Industry Co, CF Industries Holdings, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Rama Phosphates Limited stock attractive at the current price?
The data as of Sep 27, 2026: price ₹120.05, calculated fair value ₹120.41 (+0%), Quality Score 57/100, from 17 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of RAMAPHO calculated?
We run Rama Phosphates Limited through 17 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ₹120.41, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Rama Phosphates Limited itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Rama Phosphates Limited (RAMAPHO)?
The closing price on Oct 1, 2026 was ₹120.05. Our model-based fair value is ₹120.41, about +0% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Rama Phosphates Limited right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. The price sits in the lower half of our model range, the side with the larger margin of safety. The data supports the verdict: every model runs on fully documented inputs.
Key figures of Rama Phosphates Limited
How large is the market capitalisation of Rama Phosphates Limited (RAMAPHO)?
The market capitalisation of Rama Phosphates Limited is ₹4.2B (≈ $44.1M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Rama Phosphates Limited (RAMAPHO)?
The price-to-sales ratio of Rama Phosphates Limited is 0.48 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Rama Phosphates Limited (RAMAPHO)?
Earnings per share at Rama Phosphates Limited are ₹14.89 (price ÷ EPS = P/E 8.1). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Rama Phosphates Limited (RAMAPHO)?
The dividend yield of Rama Phosphates Limited is 0.6% (payout 5.0%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Rama Phosphates Limited (RAMAPHO)?
The net margin of Rama Phosphates Limited is 5.9% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Rama Phosphates Limited (RAMAPHO)?
The return on equity (ROE) of Rama Phosphates Limited is 13.3% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Rama Phosphates Limited (RAMAPHO)?
On an EBIT basis the return on assets of Rama Phosphates Limited is 2.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Rama Phosphates Limited (RAMAPHO)?
The operating margin of Rama Phosphates Limited is 3.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Rama Phosphates Limited (RAMAPHO)?
Revenue at Rama Phosphates Limited is growing +9.0% versus a year earlier (3y avg +16.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Rama Phosphates Limited (RAMAPHO)?
Earnings per share at Rama Phosphates Limited are growing +2.6% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Rama Phosphates Limited (RAMAPHO) generate?
The free cash flow of Rama Phosphates Limited is −₹135M (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Rama Phosphates Limited (RAMAPHO) carry?
The net debt of Rama Phosphates Limited is ₹1.3B (fiscal year 2026). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Rama Phosphates Limited in the live analysis
One click puts Rama Phosphates Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
